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isfolded proteins retained in the endoplasmic
reticulum (ER) are degraded by the ER-associated
degradation pathway. The mechanisms used to
sort them from correctly folded proteins remain unclear.
Analysis of substrates with deﬁned folded and misfolded
domains has revealed a system of sequential checkpoints that
recognize topologically distinct domains of polypeptides.
The ﬁrst checkpoint examines the cytoplasmic domains of
membrane proteins. If a lesion is detected, it is retained
statically in the ER and rapidly degraded without regard to
M
 
the state of its other domains. Proteins passing this test face
a second checkpoint that monitors domains localized in
the ER lumen. Proteins detected by this pathway are sorted
from folded proteins and degraded by a quality control
mechanism that requires ER-to-Golgi transport. Although
the ﬁrst checkpoint is obligatorily directed at membrane
proteins, the second monitors both soluble and membrane
proteins. Our data support a model whereby “properly
folded” proteins are deﬁned biologically as survivors that
endure a series of distinct checkpoints.
 
Introduction
 
Most proteins secreted from the cell or resident along the
secretory pathway must first traverse the membranes of the
ER. Nascent polypeptides are translocated in the unfolded
state so folding and oligomerization occur in the lumen of
the ER. For this reason, the ER maintains a full complement
of chaperones and enzymes required for folding. In addition,
maturation of many secretory proteins requires posttransla-
tional modifications that are performed by enzymes resident
in the ER. To prevent the transport of polypeptides to their
sites of function until they are properly folded, cells evolved
mechanisms termed collectively “ER quality control” (Brodsky
and McCracken, 1999; Ellgaard and Helenius, 2003). Proteins
irreversibly misfolded are degraded by the ER-associated
degradation (ERAD) pathway, an aspect of ER quality control
(Hampton, 2002; Kostova and Wolf, 2003).
Although the mechanisms underlying ER quality control
are incompletely understood, the emerging view describes a
series of requisite events that culminate with degradation.
The first step requires sorting of folded proteins from folding
intermediates and misfolded proteins. How the cell distin-
guishes the vast array of possible conformations and places
them into these broad categories is unclear. Some folded
proteins bind specific cargo receptor molecules for sorting
into COPII-coated vesicles destined for the Golgi apparatus
(Belden and Barlowe, 2001). By extension, it is conceivable
that unfolded proteins remain in the ER by default. This
type of mechanism would require that receptors recognize
folded conformations, which is not yet established. In
mammalian cells, the ER lectins calnexin and calreticulin
retain unfolded glycoproteins reglucosylated by UDP-glucose–
glycoprotein glucosyltransferase (GT; Hebert et al., 1995;
Trombetta and Helenius, 1999). Thus, GT appears to be a
factor capable of distinguishing folded and unfolded glyco-
proteins. In yeast, there is no GT equivalent but mounting
evidence suggests that the ER chaperone BiP could play a
role in conformational sorting. BiP mutants are defective in
ERAD and exhibit aggregation of misfolded proteins (Plemper
et al., 1997; Brodsky et al., 1999; Nishikawa et al., 2001).
Once sorted, misfolded proteins must be targeted for
degradation. The best available information suggests that
the key target is the Sec61 translocon, an ER membrane
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pore complex known for its role in ER protein import
(Johnson and van Waes, 1999). Thus, the translocon ap-
pears to mediate both forward and reverse translocation of
proteins across ER membranes. How the substrate is deliv-
ered to the translocon is unclear but recent works suggest
that the folding catalyst protein disulfide isomerase could
play a key role (Gillece et al., 1999; Tsai et al., 2001). For
glycoproteins, the putative lectin Htm1p/Mnl1p (EDEM in
mammals) could play a role in presenting substrates to the
translocon (Jakob et al., 2001; Nakatsukasa et al., 2001;
Molinari et al., 2003; Oda et al., 2003). On the cytosolic
side of the membrane, substrate retrotranslocation and ex-
traction is assisted by the Cdc48–Ufd1–Npl4 complex (Ye
et al., 2001; Jarosch et al., 2002; Rabinovich et al., 2002).
The substrate is next ubiquitylated by specific E2 ubiquitin
conjugating enzymes and E3 ubiquitin ligases located at the
ER membrane (Hampton et al., 1996; Hiller et al., 1996;
Bordallo et al., 1998; Bays et al., 2001). Misfolded glycopro-
teins are deglycosylated by the cytosolically localized enzyme
protein N-glycanase (Suzuki et al., 2000; Hirsch et al.,
2003). Finally, the processed substrate is deubiquitinated
and degraded by the 26S proteasome (Ward et al., 1995;
Hampton et al., 1996; Hiller et al., 1996).
The wide array of ERAD substrates confounds the idea
that a single pathway is sufficient for all the needs of ER qual-
ity control. Proteins can be soluble in the lumen or integrated
in the ER membrane. Furthermore, membrane proteins can
be composed of three distinct domains: luminal, membrane,
and cytosolic. Therefore, it is difficult to envision how a sin-
gle surveillance mechanism can inspect all classes of aberrant
secretory proteins. From studies in yeast and mammals, sev-
eral pathways operate simultaneously for quality control.
Some proteins are transported to the Golgi apparatus and re-
trieved to the ER for degradation, whereas others are stati-
cally retained (Hammond and Helenius, 1994; Caldwell et
al., 2001; Vashist et al., 2001; Yamamoto et al., 2001). In
yeast, certain misfolded proteins bypass ER quality control
entirely and are directly transported to the vacuole (the yeast
lysosome) for degradation (Hong et al., 1996; Holkeri and
Makarow, 1998; Luo et al., 2002). This pathway, termed
“Golgi quality control” (Arvan et al., 2002), also serves to de-
grade excess substrates of the ER quality control pathway in
cells under stress (Spear and Ng, 2003).
Precisely why some misfolded proteins are selected for one
pathway over others is unknown. Studies examining multi-
ple classes of ERAD substrates have provided some clues. In
yeast, substrates requiring ER-to-Golgi transport for degra-
dation are typically soluble, whereas those statically retained
are integral membrane proteins (Caldwell et al., 2001; Vash-
ist et al., 2001). From these data, we hypothesized that mis-
folded soluble proteins are sorted to the retrieval pathway,
whereas membrane proteins are statically retained before
degradation. Although the notion was appealing because of
its simplicity, the relatively small number of substrates ex-
amined left open the possibility of other models.
Here, we tested our hypothesis directly by designing a se-
ries of ERAD substrates with defined misfolded domains.
Our data show that proteins are not sorted on the basis of
their association with the membrane. Instead, the site of the
lesion is the most important determinant. Membrane pro-
teins with lesions in their cytosolic domains are retained,
whereas proteins with solely luminal lesions are sorted for re-
trieval. This suggests the existence of distinct luminal and cy-
tosolic surveillance mechanisms for ER quality control. Pro-
teins with both cytosolic and luminal lesions exclusively use
the retention pathway showing that it precedes the retrieval
pathway. Together, our data support a model by which the
quality control of secretory protein folding is comprised of a
series of checkpoints. Proteins halted at any checkpoint are
degraded. Proteins that pass all checkpoints are deemed as
“folded” and transported to their sites of function.
 
Results
 
Two distinct ERAD pathways are defined by specific 
kinetic and genetic parameters
 
Two soluble proteins, mutant carboxypeptidase Y (CPY*)
and yeast Kar2p signal sequence fused to the simian virus 5
HA-Neuraminidase ectodomain (KHN), and two mem-
brane proteins, Sec61-2p (mutant ER translocon compo-
nent) and Ste6-166p (mutant a-factor transporter), have
been studied as model substrates for ER quality control in
the budding yeast 
 
Saccharomyces cerevisiae
 
 (Finger et al.,
1993; Sommer and Jentsch, 1993; Loayza et al., 1998;
Vashist et al., 2001). Diagnostic of their identity as ERAD
substrates is the requirement of ERAD-specific ubiquityla-
tion genes for degradation and dispensability of genes re-
quired for vacuolar proteolytic function (Table I, 
 
CUE1
 
,
 
HRD1/DER3
 
, and 
 
DOA10
 
 ubiquitylation genes and the
 
PEP4
 
 gene required for vacuolar protease activation).
Before degradation, the soluble substrates are sorted into a
pathway that requires ER-to-Golgi transport, whereas the
membrane substrates are retained statically in the ER. This
difference is reflected by whether the ER-to-Golgi transport
genes 
 
SEC12
 
 and 
 
SEC18
 
 are required for degradation (Table
I) (Caldwell et al., 2001; Vashist et al., 2001). They also dif-
fer in their requirement for 
 
DER1
 
, a gene required for the
degradation of the soluble substrates but dispensable for the
membrane substrates (Table I). In addition to differences in
genetic requirements, the two classes of substrates can be
distinguished by their turnover rates. The membrane sub-
strates (
 
t
 
1/2
 
, 8–12 min) are degraded more rapidly than the
soluble substrates (
 
t
 
1/2
 
, 27–35 min). This difference is proba-
 
Table I. 
 
Membrane and soluble proteins differ in their 
requirements for degradation
Membrane proteins Soluble proteins
Sec61-2p Ste6-166p KHN CPY*
 
t
 
1/2
 
 (min) 12 8 35 27
Requires
 
CUE1
 
yes yes yes yes
 
PEP4
 
no no no no
 
SEC12
 
no no yes yes
 
SEC18
 
no no yes yes
 
DER1
 
no no yes yes
 
HRD1/
DER3
 
yes no yes yes
 
DOA10
 
ND yes no no
Data complied from Vashist et al., 2001, and this work. 
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bly a reflection of their distinctive sorting mechanisms.
Thus, the pathway used by a substrate can be characterized
by the genetic and kinetic parameters as outlined in Table I.
From the accumulated data, the simplest view suggests
that soluble substrates require the pathway involving trans-
port between the ER and Golgi apparatus, whereas mem-
brane substrates are degraded independently of transport
(Table I). However, the locations of genetic lesions raised
a second possibility. Both Sec61-2p and Ste6-166p con-
tain mutations mapped in or near their cytosolic domains
(Sec61-2p: Gly213 to Asp; Ste6-166p: Gln1249 to stop that
truncates 42 aa), whereas misfolded portions of the soluble
substrates are entirely luminal (Finger et al., 1993; Loayza et
al., 1998; Nishikawa et al., 2001). This suggests that the site
of lesion with respect to the ER membrane could be a major
determinant. To distinguish these possibilities, we con-
structed and analyzed a series of chimeric molecules with de-
fined folded and misfolded domains.
 
The site of lesion determines the pathway used
 
First, we analyzed an integral membrane substrate designed to
be misfolded exclusively in the luminal domain. If all types of
misfolded membrane proteins are statically retained as a rule,
we expect it to be degraded independently of vesicular trans-
port. Dependence on 
 
SEC12
 
 and 
 
SEC18
 
 would support the
alternative model. This substrate was created by replacing the
luminal/extracellular domain of Wsc1p with KHN. Wsc1p is
a nonessential signaling protein anchored by a single trans-
membrane domain in the type I orientation (N
 
out
 
C
 
in
 
; Lodder
et al., 1999). As a plasma membrane protein, it does not con-
tain intrinsic ER retention signals that might indirectly influ-
ence its targeting for ERAD. KHN was selected for the lumi-
nal domain because it contains O-linked sugars that are
modified after transport to the Golgi apparatus. The modifi-
cation provides a convenient localization marker that can be
monitored by a characteristic shift in gel mobility (Vashist et
al., 2001). The chimeric molecule, designated KHN luminal
domain/Wsc1p transmembrane domain/Wsc1p cytosolic do-
main (KWW), is schematically depicted in Fig. 1.
To determine if KWW is indeed an integral membrane
protein, we prepared a zirconium bead–disrupted extract
from wild-type cells expressing the protein and subjected it
to alkali. Under these conditions, soluble and peripherally
associated membrane proteins are extracted from mem-
branes. These can be subsequently separated from integral
membrane proteins by centrifugation. As shown in Fig. 2 A,
KWW was found exclusively in the pellet fraction along
with the Sec61p membrane protein control. The soluble lu-
minal protein Kar2p partitioned into the supernatant frac-
tion, as expected. These data confirm that KWW is a bona
fide integral membrane protein.
KWW was designed to maintain a type I membrane ori-
entation by including Wsc1p membrane flanking sequences
that are important determinants (Hartmann et al., 1989).
We confirmed the orientation using two methods. First, we
analyzed the N-linked glycosylation pattern of KWW. Each
N-linked carbohydrate decreases the gel mobility of yeast
glycoproteins by 
 
 
 
2 kD. KHN contains four N-linked gly-
cosylation sites, whereas the cytosolic domain of Wsc1p
contains only a single cryptic site. Thus, correctly oriented
KWW exhibits a substantial shift when deglycosylated,
whereas a minor shift would be observed if misoriented.
Wild-type cells expressing KWW were pulse labeled, KWW
immunoprecipitated, and digested with endoglycosidase H
(Endo H) to remove N-linked sugars. As shown in Fig. 2 B,
deglycosylated KWW migrated at a position consistent with
an 8-kD shift. Notably, glycosylated KWW migrated as a
single species indicating only one membrane orientation. As
a second approach, we applied a microsome protease-pro-
tection assay. Because the portion carboxyl-proximal to
the transmembrane domain contributes 10 kD to KWW,
whereas the amino-terminal portion contributes 67 kD (not
including N- and O-linked sugars if properly oriented), the
size of the protected fragment provides an unambiguous de-
termination of membrane orientation. A membrane fraction
was prepared from cells expressing KWW and digested with
proteinase K or mock treated. As shown in Fig. 2 C, pro-
tease treatment generated a protected KWW fragment that
migrates in SDS-PAGE consistent with a 10-kD reduction
in size. Recognition of this fragment by the HA mAb further
confirms the luminal orientation of the KHN domain as the
epitope is located there. These data show that KWW is a
type I integral membrane protein.
To determine which pathway degrades KWW, we moni-
tored its turnover in wild-type and mutant strains using
metabolic pulse-chase experiments. With a 
 
t
 
1/2
 
 of 35 min,
KWW was degraded at a rate similar to KHN and CPY* and
much slower than the membrane substrates Ste6-166p and
Sec61-2p (Fig. 2 D). Strains deleted of the ERAD-related
genes 
 
CUE1
 
 and 
 
HRD1/DER3
 
, required for substrate ubiq-
uitylation, stabilized KWW confirming its degradation by
the ERAD pathway. Interestingly, KWW also required
 
DER1
 
, an ERAD gene required by many misfolded soluble
proteins (Fig. 2 D and Table I; Knop et al., 1996a; Vashist
et al., 2001). These data provide the first evidence that
 
DER1
 
 plays a role in degrading misfolded integral mem-
brane proteins. We also noticed that KWW acquired a mo-
bility shift during the time course suggesting that some mol-
ecules were transported to the Golgi apparatus. To support
this assertion and demonstrate that KWW degradation re-
quires vesicular transport, we measured its turnover in
 
sec12-4
 
 and 
 
sec18-1
 
 mutant strains. 
 
SEC12
 
 is required for
vesicle budding from the ER and 
 
SEC18
 
 is required for vesi-
cle fusion to the Golgi apparatus (Eakle et al., 1988; Nakano
et al., 1988; Barlowe and Schekman, 1993). In both strains,
Figure 1. Schematic representation of substrates. The engineered 
ERAD substrates bear three letter designations that describe their 
composition. The first, second, and third letters represent the luminal, 
transmembrane, and cytosolic domains, respectively. For each protein, 
KHN is symbolized by dark gray stars, Wsc1p portions by light gray 
bars (transmembrane) and circles (folded cytosolic and luminal 
domains), and Ste6-166p by black bars/loops (transmembrane), 
black circles (folded cytosolic domain), and black stars (misfolded 
cytosolic domain). 
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KWW was stabilized confirming that it uses the same path-
way as the soluble substrates (Fig. 2 E). Furthermore, the
lack of a mobility shift in these strains confirmed that it was
not subject to static ER retention. These data rule out the
hypothesis that the retrieval pathway is specific for soluble
substrates, whereas membrane substrates exclusively use the
static retention pathway. As a membrane protein misfolded
only in its luminal domain, KWW shows that the site of le-
sion is the major determinant used for sorting substrates.
 
Sequential checkpoints are used to monitor 
protein folding
 
The data suggest the existence of at least two surveillance
mechanisms for ER protein folding: one that inspects lumi-
nal domains (soluble or membrane proteins) and another
that inspects cytosolic domains (membrane proteins). We
propose to use the designations ERAD-L (ERAD-Luminal)
and ERAD-C (ERAD-Cytosolic) to describe these path-
ways. Because the two pathways ultimately converge at the
proteasomal degradation step, we wondered about their
functional relationship. Do they compete for substrates or
do they maintain an ordered relationship whereby one path-
way precedes the other (the checkpoint model)?
To test this question, we created a substrate containing
determinants for both pathways. For this, we fused KHN to
Ste6-166p. We selected Ste6-166p because it is retained by
ER quality control rather than by an intrinsic signal, which
is possible for Sec61-2p. Unlike the other substrates, the E3
ubiquitin ligase for Ste6-166p was not known as it is de-
graded efficiently in a strain lacking Hrd1p/Der3p (Fig. 3
A). We searched for the E3 enzyme required by Ste6-166p
as it might lead to the identification of a factor devoted to
the surveillance of cytosolic domains. It was reported previ-
ously that the ER-anchored E3 ligase Doa10p is required for
the degradation of Ubc6p, an ER membrane protein with
its globular domain cytosolically oriented (Swanson et al.,
2001). To determine whether it might also play a role in the
degradation of misfolded membrane proteins, we analyzed
the turnover of Ste6-166p in a 
 
 
 
doa10
 
 strain. As shown in
Fig. 3 B, Ste6-166p was stabilized in 
 
 
 
doa10
 
 cells. More-
over, a double 
 
 
 
hrd1/der3
 
 
 
doa10
 
 mutant exhibited the
strongest stabilization suggesting that Hrd1p/Der3p can
partly compensate when Doa10p is absent (unpublished
data). By contrast, 
 
DOA10
 
 is not required for the degrada-
tion of ERAD-L substrates CPY* (Swanson et al., 2001),
KWW (Fig. 3 C), or KHN (unpublished data).
To construct KSS (KHN luminal/Ste6p transmembrane
domains/Ste6-166p cytosolic mutant domain), we fused
KHN to the second transmembrane domain of Ste6-166p
to direct KHN to the luminal side (Fig. 1). Translocation of
KSS is directed by the cleaved Kar2p signal sequence located
at the amino terminus of the KHN portion (Vashist et al.,
2001). Alkali carbonate extraction experiments confirmed
that KSS is a bona fide integral membrane protein (Fig. 4
Figure 2. KWW is degraded by the ERAD-L 
pathway. (A) Cells expressing KWW were meta-
bolically labeled with [
35S]methionine/cysteine for 
20 min. Cell lysates were prepared and incubated 
in 0.1 M of sodium carbonate, pH 11.0, for 30 min 
at 4 C and the membrane fraction separated by 
centrifugation. Proteins were immunoprecipitated 
from total (T), pellet (P), and supernatant (S) fractions. 
Sec61p and Kar2p serve as controls for integral 
membrane and soluble proteins, respectively. KWW 
was immunoprecipitated using anti-HA mAb (HA.11; 
Covance) and resolved by electrophoresis using 
10% SDS polyacrylamide gels. (B) Cells expressing 
KWW were labeled with [
35S]methionine/cysteine 
for 10 min. KWW immunoprecipitates were mock 
treated ( ) or digested ( ) with Endo H, resolved 
by SDS-PAGE, and visualized by autoradiography. 
(C) Protease protection assay. Wild-type cells 
expressing KWW were pulse labeled for 10 min 
and a fraction containing cytosol and membranes 
was prepared. The extracts were split and treated 
with proteinase K in the presence or absence of 
Triton X-100 or mock treated. KWW was immuno-
precipitated and analyzed by SDS-PAGE (8%) and 
autoradiography. (D) Wild-type and mutant strains 
expressing KWW were pulse labeled for 10 min with 
[
35S]methionine/cysteine followed by cold chase 
for times indicated. Immunoprecipitated proteins 
were analyzed by electrophoresis on 8% gels and 
visualized by autoradiography. (E) Wild-type, 
sec12-4, and sec18-1 strains were grown to log 
phase at 22 C and shifted to the restrictive temper-
ature (37 C) for 30 min before pulse-chase analysis 
as described for D. The data were quantified by 
PhosphorImager analysis and plotted as mean 
values with SDs of two independent experiments 
(D and E). Representative autoradiograms are shown. 
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A). To confirm that the KHN portion of KSS is luminal,
Endo H analysis was performed as described in Fig. 2 B. Fig.
4 B shows that KSS is glycosylated, whereas the control,
Ste6-166p, is nonglycosylated. This experiment shows that
the KHN portion is localized in the lumen.
Next, we determined the nature of KSS degradation. In
wild-type cells, KSS was degraded very rapidly with a 
 
t
 
1/2
 
 of
 
 
 
10 min (Fig. 4 C). This rate is similar to the ERAD-C
substrates Ste6-166p and Sec61-2p, and much faster than
KWW despite KSS being more than twice as large. The deg-
radation is ERAD specific because it was strongly stabilized
in the 
 
 
 
cue1
 
 strain (Fig. 4 C) and degraded with wild-type
kinetics in a 
 
 
 
pep4
 
 strain (unpublished data). In 
 
sec12-4
 
 and
 
sec18-1
 
 mutant strains, the degradation rates were indistin-
guishable to wild type indicating that KSS uses the same
pathway as Ste6-166p (Fig. 4 D). Notably, KSS degradation
was independent of 
 
DER1
 
 despite containing the KHN do-
main that, by itself or anchored to a normal transmembrane
protein, is 
 
DER1
 
 dependent (Fig. 4 E). Like Ste6-166p, KSS
degradation was dependent on 
 
DOA10
 
 (Fig. 4 F). These data
show that KSS is degraded exclusively by the ERAD-C path-
way despite displaying determinants for both pathways. We
conclude that the ERAD-C pathway precedes the ERAD-L
pathway as two sequential checkpoints of ER quality control.
Because the ERAD-L pathway inspects the folding of lumi-
nal domains, we wished to determine whether the ERAD-C
pathway inspects cytosolic domains of membrane proteins.
The sites of the 
 
sec61-2
 
 and 
 
ste6-166
 
 mutations and our
experiments with KSS support this notion. However, it
remained possible that the lesions disrupted interactions
between the membrane segments, which, in turn, were recog-
nized as aberrant. To determine if the misfolded cytosolic
domain of Ste6-166p is sufficient for recognition by the
ERAD-C pathway, we replaced the native cytosolic domain of
KWW with the cytosolic domain of Ste6-166p containing the
mutation. The resulting molecule, designated KHN luminal
domain/Wsc1p transmembrane domain/Ste6-166p mutant
cytosolic domain (KWS), is schematically depicted in Fig. 1.
Using the assays used for KWW, we confirmed that KWS
is a type I integral membrane protein (Fig. 5, A–C). When
expressed in wild-type cells, KWS was degraded rapidly with
a 
 
t
 
1/2
 
 of 
 
 
 
5 min and stabilized in the 
 
 
 
cue1
 
 ERAD mutant
(Fig. 5 D). Interestingly, KWS is the most rapidly degraded
ERAD substrate we have examined so far. This might reflect
its smaller size compared with Ste6-166p and KSS, or alter-
natively, as a single pass membrane protein it might be easier
to extract from the membrane. Its rapid kinetics is consistent
with degradation by the ERAD-C pathway. This notion was
confirmed by the observation that ER-to-Golgi blocks have
no effect on their turnover (Fig. 5 E). Furthermore, tests
with 
 
 
 
der1
 
, 
 
 
 
hrd1/der3
 
, and 
 
 
 
doa10
 
 mutant strains show
that KWS share the same requirements as Ste6-166p and
KSS (Fig. 5, F–H; Table II). Because KWS has determinants
for both pathways, these data show that a misfolded cytoso-
Figure 3. Ste6-166p requires the Doa10p E3 
ubiquitin ligase for degradation. (A and B) Ste6-
166p turnover was measured in wild-type,  hrd1/
der3, and  doa10 strains by pulse-chase assay as 
described in Fig. 2, except that cells were pulse 
labeled for 5 min followed by shorter times of chase. 
(C) The rate of KWW degradation was determined in 
wild-type and  doa10 cells as described in Fig. 2. 
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lic domain is sufficient to direct a substrate to the ERAD-C
pathway of ER quality control.
 
Htm1p/Mnl1p is required for glycoprotein degradation 
in the ERAD-L pathway but dispensable for the 
ERAD-C pathway
 
Recently, an ER-localized lectin called Htm1p/Mnl1p
(EDEM in mammals) was found to be required for the
degradation of misfolded glycoproteins (Jakob et al., 2001;
Nakatsukasa et al., 2001; Molinari et al., 2003; Oda et al.,
2003). Because the lectin domain of Htm1p/Mnl1p ori-
ents to the ER lumen, we wondered whether it functions
specifically in the ERAD-L pathway or if it is required for
the degradation of all misfolded glycoproteins. For this
question, we analyzed a strain deleted of the 
 
HTM1/MNL1
 
gene. As expected, KHN and KWW degradation was de-
Figure 4. KSS is degraded by the ERAD-C pathway. 
(A) Carbonate alkali extraction assay was performed 
on wild-type cells expressing KSS as described in 
Fig. 2. (B) Cells expressing Ste6-166p or KSS were 
labeled with [
35S]methionine/cysteine for 5 min 
and substrates immunoprecipitated from detergent 
lysates. N-linked carbohydrates were removed by 
Endo H digestion, proteins resolved by SDS-PAGE 
(7% gel), and visualized by autoradiography. (C) 
Wild-type and  cue1 cells expressing KSS were 
labeled for 5 min with [
35S]methionine/cysteine 
and chased for times indicated. KSS was resolved 
by electrophoresis using a 7% SDS polyacrylamide 
gel. (D) ER-to-Golgi transport is not required for 
degradation of KSS. Wild-type, sec12-4, and sec18-1 
strains were grown to log phase at 22 C and then 
shifted to the restrictive temperature (37 C) for 
30 min. (E and F) KSS turnover in  der1 and  doa10 
cells was performed as described for C. 
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Figure 5. A misfolded cytosolic domain directs 
entry to the ERAD-C pathway. (A) Carbonate alkali 
extraction assay of KWS expressed in wild-type cells 
was performed as described in Fig. 2. T, total; P, pellet; 
S, supernatant. (B) KWS expressed in wild-type cells 
was pulse labeled for 5 min, immunoprecipitated, 
mock treated ( ) and digested ( ) with Endo H, and 
resolved by SDS-PAGE. (C) Protease protection assay 
was performed to determine the orientation of KWS in 
wild-type cells as described in Fig. 2, except that the 
proteins were resolved using a 10% polyacrylamide 
gel. (D–H) KWS stability was measured in wild-type 
and indicated mutant strains as described in Fig. 4. 
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fective in 
 
 
 
htm1/mnl1
 
 cells (Fig. 6, A and B). This result is
in agreement with its proposed role in the processing of
both soluble and membrane-integrated glycoproteins for
ERAD (Jakob et al., 2001). However, KWS was degraded
as efficiently in 
 
 
 
htm1/mnl1
 
 cells as wild type (Fig. 6 C).
This occurred despite KWS containing the misfolded gly-
coprotein domain that renders KHN and KWW depen-
dent on HTM1/MNL1. These data provide evidence that
Htm1p/Mnl1p functions in the ERAD-L pathway. How-
ever, it is not required for substrates subject to the ERAD-C
pathway even if the substrate contains a large glycosylated
luminal domain.
Discussion
It is now well established that cells use multiple mechanisms
to monitor the folded states of secretory proteins (Arvan et
al., 2002). Remarkably, these mechanisms extend beyond
the ER. Nonnative versions of   repressor, NGF receptor,
and the plasma membrane ATPase (Pma1p, specific vari-
ants) are not subject to ERAD but transported directly to
the vacuole for degradation (Hong et al., 1996; Holkeri and
Makarow, 1998; Luo et al., 2002). In most cases, the vacu-
olar sorting machinery at the Golgi apparatus is required for
trafficking these molecules. Therefore, the Golgi apparatus
serves as a distal checkpoint capable of sorting misfolded
proteins that escaped detection by ER quality control or be-
came damaged after transport (Arvan et al., 2002). Beyond
the Golgi apparatus exists yet another checkpoint. Some
nonnative proteins that evade both ER and Golgi quality
control mechanisms are able to reach the plasma membrane.
However, once there, residency is transient as they are rap-
idly endocytosed and degraded by vacuolar/lysosomal pro-
teases (Ferreira et al., 2002; Fayadat and Kopito, 2003). The
mechanism for their recognition is not known. Together,
these studies show that quality control is composed of multi-
ple checkpoints throughout the secretory pathway, with
each layer contributing added stringency.
Under certain circumstances, ERAD substrates will use
the distal Golgi checkpoint. During severe ER stress, when
Table II. Degradation profiles of substrates used in this work
ERAD-C substrates ERAD-L substrates
Ste6-166p KSS KWS KHN KWW
t1/2 (min) 8 10 4 35 35
Requires CUE1 yes yes yes yes yes
PEP4 no no no no no
SEC12 no no no yes yes
SEC18 no no no yes yes
DER1 no no no yes yes
HTM1/MNL1 no no no yes yes
HRD1/DER3 no no no yes yes
DOA10 yes yes yes no no
Figure 6. The Htm1p/Mnl1p ER lectin functions 
in the ERAD-L pathway. (A–C) Wild-type and 
 htm1/mnl1 mutant strains expressing KHN, KWW, 
or KWS were analyzed for substrate turnover as 
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the unfolded protein response is activated, excess ERAD
substrates are transported to the vacuole for degradation
(Spear and Ng, 2003). Genes constituting the ER-to-vacu-
ole transport pathway including vacuolar proteases are acti-
vated by the unfolded protein response suggesting that this
alternative route is preprogrammed into the ER stress re-
sponse (Travers et al., 2000). Indeed, mutants of the BST1
and ERV29 genes that are needed for the vesicular traffick-
ing of misfolded proteins are hypersensitive to ER stress
(Spear and Ng, 2003). Together, the studies show that al-
though the Golgi checkpoint is needed for substrates not
recognized by ER quality control, it also serves as an alterna-
tive degradation pathway when ERAD is saturated.
In this paper, we demonstrate that two previously recog-
nized pathways of ER quality control constitute two sequen-
tial checkpoints. From these and other studies, we propose
the following model. At the ER, ERAD-C pathway moni-
tors the folding state of cytosolic domains of membrane pro-
teins and rapidly clears detected proteins from the ER. This
occurs without regard to the state of the luminal domain.
Should the conformation of cytosolic domains pass the
ERAD-C checkpoint, the ERAD-L pathway will monitor
the state of luminal domains. If a lesion is detected, the pro-
tein is processed for ERAD using a distinct set of factors not
required for the ERAD-C pathway. These include the ve-
sicular trafficking machinery, Bst1p, BiP and cofactors,
Der1p, the P-type ATPases Cod1p and Pmr1p, Mns1p, and
Htm1p/Mnl1p (Knop et al., 1996a,b; Durr et al., 1998;
Brodsky et al., 1999; Cronin et al., 2000; Jakob et al., 2001;
Vashist et al., 2001). Naturally, all soluble proteins bypass
the ERAD-C pathway, as they are entirely luminal. Once
passing these, and possibly other, ER checkpoints, non-ER
proteins are transported to the Golgi apparatus where they
face another checkpoints. Once all checkpoints are passed,
the protein is finally transported to its site of function.
Asymmetric recognition of substrates requires a comple-
ment of factors on both sides of the membrane. However,
the degradation machinery itself is located exclusively on the
cytosolic face of the ER membrane. Thus, cytosolic determi-
nants have the potential to form direct contacts with ex-
traction and degradation factors, whereas proteins with ex-
clusively luminal determinants must first be targeted to
membrane channels for dislocation before they can be de-
graded. This might account for the difference in degradation
kinetics of the two pathways. Despite this mechanistic dif-
ference, analogous luminal and cytosolic factors required for
ERAD have been identified. The ER chaperone BiP (lumi-
nal Hsp70 homologue) is required for CPY* degradation
and not cystic fibrosis transmembrane conductance regula-
tor (CFTR). Conversely, cytosolic Hsp70 is required for
CFTR and not CPY* (Zhang et al., 2001). Because CPY* is
a substrate of the ERAD-L pathway and CFTR is a substrate
of the ERAD-C pathway in yeast (Fu and Sztul, 2003), it is
tempting to speculate that these chaperones are responsible
for recognition and sorting of misfolded proteins for ER
quality control. They certainly are qualified to play the role
as both are known to preferentially bind unfolded proteins.
Although the proposed model accounts for a range of sub-
strates, there is evidence of additional checkpoints. Our
studies explored the role of misfolded luminal and cytosolic
domains but did not examine the effects of misfolded or un-
assembled transmembrane domains, a key determinant for
some substrates. For example, unassembled  -subunits of
the T cell receptor are retained in the ER and rapidly de-
graded by ERAD. The determinant (termed “degron”) has
been mapped to specific residues in the transmembrane do-
main that are responsible for recognition by ER quality con-
trol when the segment is not partnered with other subunits
(Bonifacino et al., 1991). The mechanism for the surveil-
lance of membrane segments is unknown. Thus, the exist-
ence of a distinct ERAD-Membrane pathway remains a pos-
sibility that awaits further study. For soluble substrates, the
nonglycosylated form of pro–  factor, does not require ER-
to-Golgi transport for degradation in vitro (McCracken and
Brodsky, 1996) or in vivo (unpublished data). It also does
not require ubiquitylation but is degraded by the protea-
some. It requires the ER lectin calnexin, whereas substrates
of the ERAD-L pathway like CPY* do not (McCracken and
Brodsky, 1996). Thus, it likely represents a distinct ER
checkpoint for soluble proteins. Its faster rate of degradation
suggests that it might precede the ERAD-L checkpoint de-
scribed in our work.
In a recently published work, membrane-bound versions
of CPY* were expressed and assessed for their genetic re-
quirements in ERAD (Taxis et al., 2003). The analysis al-
lowed investigators to propose a general ERAD machinery
composed of the ubiquitin conjugating enzymes Ubc1p
and Ubc7p, ubiquitin ligase complex Hrd1p–Der3p–
Hrd3p, the Cdc48p–Ufd1p–Npl4p complex, and the
proteasome. Our studies show that additional ubiquityla-
tion machinery is required for other classes of substrates,
notably of the ERAD-C pathway. Doa10p is required for
the degradation of Ste6-166p, KSS, and KWS, whereas
Hrd1p/Der3p is dispensable. Interestingly, the molecules
membrane-bound CPY* lacking a cytosolic domain (CT*)
and CT* with GFP as its cytosolic domain (CTG*) were
degraded without DER1 or KAR2 functions, which are
requirements of soluble CPY*. Because these substrates
would be predicted to bypass ERAD-C (no cytosolic do-
main in CT* and folded GFP in CTG*), these data do not
conform to our model. However, differences in the experi-
mental designs could account for the apparent discrepancy.
The simplest explanation is that the CT* and CTG* pro-
teins were overexpressed from the constitutive TDH3 pro-
moter (Taxis et al., 2003). Previous studies have shown
that cell stress caused by increasing the load of CPY* acti-
vates degradation pathways that can function indepen-
dently of HRD and DER genes (Haynes et al., 2002; Spear
and Ng, 2003). All the substrates examined in the current
work were expressed at levels that do not saturate the basal
ERAD machinery. A second difference lies in the design of
the chimeric substrates. The single transmembrane seg-
ment of CT* and CTG* was acquired from the multi-
spanning membrane protein Pdr5p. Thus, it seems plausi-
ble that the transmembrane segment of CT* and CTG*,
out of its native environment (of likely interactions with
other Pdr5p segments), contributes to the degradation that
is independent of Der1p and Kar2p. In support of this
possibility, it is well established that transmembrane seg-
ments with significant hydrophilic content are determi-50 The Journal of Cell Biology | Volume 165, Number 1, 2004
nants of ER retention and/or degradation when isolated
from their partner sequences (Bonifacino et al., 1991; Le-
tourneur and Cosson, 1998; Sato et al., 2003). Indeed,
inspection of the selected Pdr5p transmembrane core
sequence revealed a high number of polar residues (4 ty-
rosine and 2 asparagine). By contrast, the hydrophobic
core of the sole Wsc1p transmembrane domain is devoid of
hydrophilic residues.
With the ever-increasing number of misfolded protein
substrates examined, it is clear that the variety of determi-
nants or degrons is extensive. Correspondingly, it is now
appreciated that protein quality control is comprised of
multiple mechanisms housed in several organelles and the
cytosol. Although the mechanisms remain poorly defined,
the list of players is growing rapidly. Placement of key fac-
tors into defined pathways with their client substrates is
an important step toward the goal of fully understanding
how “bad” proteins are sorted from “good” proteins for
destruction.
Materials and methods
Plasmids used in this work
Plasmids were constructed using standard cloning protocols. HA epitope-
tagged Ste6-166p was expressed from pSM1083 and was a gift from S.
Michaelis (Johns Hopkins University, Baltimore, MD; Loayza et al., 1998).
All ERAD substrates used in this work contain an engineered HA epitope
tag. KHN (pSM70) is the same as KHNt described previously (Vashist et al.,
2001). The three-letter designation is used for simplicity and to avoid con-
fusion with the designations of other substrates.
pSM101 (KWW): The gene encoding KWW was constructed by ligating
the coding sequences of KHN (pSM70; Vashist et al., 2001) to sequences
encoding transmembrane and cytosolic domains of WSC1. A 1.6-kb frag-
ment containing KHN was amplified using Vent DNA polymerase and
primers N193 (5 -GGGATCGATAGTTTAATAACCCAAAAGCA-3 ) and
N253 (5 -GCACTGAGCAGCGTAATCTGG-3 ). A 500-bp fragment was re-
leased from the 3  end after digestion with BstEII and purified. A second
fragment was prepared by amplifying a 697-bp fragment of WSC1 using
the primers N254 (5 -AAGAAAGCCAATGTAGGGGCA-3 ) and N256 (5 -
GCGTCTAGATATTAGGTGGTATTCATTTCA-3 ) and digested with XbaI.
Both fragments were ligated into pSM70 digested with BstEII and XbaI to
generate pSM101. A triple HA epitope tag is located at the junction of the
gene fusion from fragment 1.
pSM114 (KSS): KSS is a fusion between KHN and Ste6-166p. This chi-
mera was generated in three steps. First, a fusion was created between
KHN and the sequence encoding amino acids 69–403 of Ste6-166p using
the PCR-based approach described above. A 1.6-kb fragment was ampli-
fied using N193 and N253 primers and digested with ClaI. A second 1.0-
kb fragment was amplified from STE6 using N294 (5 -TCCCAACTAGTA-
CAGAGG-3 ) and N295 (5 -GTTGGATAATGTAGATTTACC-3 ) and di-
gested with XbaI. Both fragments were inserted into pDN121 (a variant of
pRS314) digested with ClaI and XbaI to form the KHN/Ste6p junction. The
remaining 3  coding sequences of Ste6-166p was inserted into the inter-
mediate construct to generate pSM108. A GAS1 promoter was inserted up-
stream of the coding sequences to generate pSM114.
pSM118 (KWS): A 0.9-kb fragment was amplified from pSM101 using
primers N360 (5 -CATACTATAGCAGCTGGTTTGGC-3 ) and N390 (5 -
TCTGACAATCAACAAGATACAAAGAGC-3 ), digested with BstEII and the
0.6-kb fragment purified. A fragment encoding the mutant cytosolic do-
main of Ste6-166p was amplified from pSM1083 using primers N392 (5 -
Table III. Strains used in this work
Strain Genotype Source
W303 Mata, leu2-3,112, his3-11, trp1-1, can1-100, ade2-1 P. Walter
a
SMY489 Mata, W303, pSM101 This paper
SMY490 Mata, cue1::TRP1, pSM101, W303 background This paper
SMY491 Mata, der1::KANMX, pSM101, W303 background This paper
SMY492 Mata, hrd1/der3::KANMX, pSM101, W303 background This paper
SMY628 Mata, doa10::KANMX, pSM101, W303 background This paper
SMY496 Mata, sec12-4, pSM101, W303 background This paper
SMY497 Mata, sec18-1, pSM101, W303 background This paper
SMY371 Mata, W303, pSM1083 This paper
SMY613 Mata, hrd1/der3::KANMX, pSM1083, W303 background This paper
SMY601 Mata, doa10::KANMX, pSM1083, W303 background This paper
SMY610 Mata, W303, pSM114 This paper
SMY614 Mata, cue1::TRP1, pSM114, W303 background This paper
SMY611 Mata, der1::KANMX, pSM114, W303 background This paper
SMY615 Mata, hrd1/der3::KANMX, pSM114, W303 background This paper
SMY612 Mata, doa10::KANMX, pSM114, W303 background This paper
SMY626 Mata, sec12-4, pSM114, W303 background This paper
SMY627 Mata, sec18-1, pSM114, W303 background This paper
SMY639 Mata, W303, pSM118 This paper
SMY641 Mata, cue1::TRP1, pSM118, W303 background This paper
SMY656 Mata, der1::KANMX, pSM118, W303 background This paper
SMY661 Mata, hrd1/der3::KANMX, pSM118, W303 background This paper
SMY652 Mata, doa10::KANMX, pSM118, W303 background This paper
SMY645 Mata, sec12-4, pSM118, W303 background This paper
SMY647 Mata, sec18-1, pSM118, W303 background This paper
SMY500 Mata, pep4::HIS3, pSM101, W303 background This paper
WKY753 Mata, htm1/mnl1::KANMX4, pSM70, W303 background This paper
WKY754 Mata, htm1/mnl1::KANMX4, pSM101, W303 background This paper
WKY755 Mata, htm1/mnl1::KANMX4, pSM118, W303 background This paper
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ATACCCGATATAAGTAGAGGCCAACGT-3 ) and N410 (CGCTCTAGAT-
TATTCACTATGCGTTATAACC) and digested with XbaI. These fragments
were simultaneously inserted into pSM101 digested with BstEII and XbaI.
Strains and antibodies
Strains used in this work are listed in Table III. Anti-HA mAb was pur-
chased from BabCo. Polyclonal antisera specific for Kar2p and Sec61p
were provided by P. Walter (University of California, San Francisco, San
Francisco, CA).
Cell labeling and immunoprecipitation
Typically, 3 OD600 U of log phase cells were pelleted and resuspended in
synthetic media lacking uracil, methionine, and cysteine. After 30 min of
incubation at the appropriate temperature, 480  Ci of Trans 
35S-label was
added to initiate a pulse. Cells were labeled for 5 or 10 min as described in
the figure legends. Cold methionine and cysteine were added (to a final
concentration of 2 mM each) 30 s before end of the pulse to initiate the
chase. Termination of the chase was performed by the addition of TCA (fi-
nal concentration of 10%). TCA precipitates were resuspended and boiled
in 100 mM Tris, pH 11.0, and 3% SDS for 5 min. Immunoprecipitations
were performed by incubating in immunoprecipitation solution (50 mM
Tris, pH 7.5, 1% Triton X-100, 150 mM NaCl) and appropriate antibody
for 1 h at 4 C. The samples were centrifuged at 20,000 g for 20 min and
transferred to fresh tubes containing protein A–Sepharose beads. The sam-
ples were incubated with beads on a rocking platform for 2 h at 4 C. After
incubation, the samples were washed twice with high salt immunoprecipi-
tation solution (50 mM Tris, pH 7.5, 1% Triton X-100, 300 mM NaCl),
twice with low salt solution (50 mM Tris, pH 7.5, 1% Triton X-100, 150
mM NaCl) and twice with PBS. Proteins were separated by electrophoresis
using SDS-polyacrylamide gels of varying composition as indicated in the
figure legends and visualized by autoradiography. Quantification was per-
formed from PhosphorImager scans of polyacrylamide gels using Im-
agequant software (Molecular Dynamics).
Protein deglycosylation
Immunoprecipitated proteins on washed protein A–Sepharose beads were
denatured in SDS and digested with Endo H (New England Biolabs, Inc.)
according to the manufacturer’s protocol. Control samples were processed
identically except that the enzyme was omitted during incubation.
Alkaline carbonate extraction
10 OD600 U of cells expressing KWW, KSS, or KWS were labeled using
Trans 
35S-label for times indicated in the legend to Fig. 2. The pulse was
terminated by addition of 20 mM sodium azide. Cells were pelleted by
20,000  g centrifugation, washed once with ice-cold water, and resus-
pended in buffer (10 mM sodium phosphate, pH 7.0, 1 mM PMSF, and 1 
yeast protease inhibitor cocktail; Sigma-Aldrich). Cell disruption was per-
formed by vortexing at maximum setting with zirconium beads at 4 C. Un-
broken cells and debris were separated from membranes by two succes-
sive low speed centrifugation steps at 500 g for 5 min each. The
supernatant fraction was treated with sodium carbonate, pH 11.0, for 30
min on ice. One third was removed, precipitated in 10% TCA on ice for 30
min, and saved. The remaining was fractionated by centrifugation at
100,000 g for 30 min at 4 C. The pellet fraction was washed once in wa-
ter, resuspended in 3% SDS, 100 mM Tris, pH 7.5, 3 mM DTT, and heated
for 5 min at 95 C. The supernatant fraction was incubated in 10% TCA and
precipitates were collected by centrifugation. TCA precipitated proteins
were resuspended in 100 mM Tris, pH 11.0, 3% SDS, 3 mM DTT, and
heated to 95  C for 5 min. Detergent lysates were adjusted to reflect equiv-
alent cell numbers, immunoprecipitated, and analyzed by SDS-PAGE.
Protease protection assay
To determine membrane orientation of substrate proteins, 12 OD600 U of
cells were grown to log phase and metabolically labeled with Trans 
35S-
label for 10 min. Labeling was terminated with the addition of sodium
azide to a final concentration of 20 mM. Cells were harvested by low
speed centrifugation and washed once in ice-cold water. Cells were then
resuspended in 25 mM sodium phosphate, pH 7.0, and disrupted by vor-
texing at full speed in the presence of zirconium beads. Cell debris was
separated using two successive centrifugation steps, each at 500 g for 5
min, and discarded. The remaining fraction containing membranes and cy-
tosol was split into three aliquots. To two aliquots, proteinase K (5  g/ml fi-
nal concentration; IBI) was added, with or without Triton X-100 (1% final
concentration). The third was mock treated. All samples were incubated
on ice for 10 min. To terminate the reaction, PMSF was added to final con-
centration of 10 mM. Proteins were precipitated by the addition of TCA
(10% final concentration). Detergent lysates were prepared and immuno-
precipitations were performed as described above.
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